IDE-161

N/A

Report date: 2026/02/10 20:00:22
NMEFirst In Class

Base Information

Drug NameIDE-161
Drug Alias NameIDE-161
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPoly(ADP-ribose) glycohydrolase inhibitors
TargetsPoly(ADP-ribose) glycohydrolase
Therapy Area/IndicationsSolid tumoursProstatic NeoplasmsEndometrial Neoplasms +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesIdeaya Biosciences Inc
China Registration ClassN/A

Develop Information

Active CompaniesIdeaya Biosciences Inc
Inactive CompaniesN/A
Active IndicationsSolid tumoursProstatic NeoplasmsEndometrial Neoplasms +[9] 
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A